Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation

NCT04901689 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

316

Enrollment

OTHER

Sponsor class

Stopped Pending DSMB evaluation

Conditions

COVID-19 Pneumonia

Interventions

DRUG: Leronlimab
DRUG: Placebo

Sponsor

Hospital Israelita Albert Einstein

Collaborators

[object Object]